151. Small Extracellular Vesicles from adipose derived stromal cells significantly attenuate in vitro the NF-κB dependent inflammatory/catabolic environment of osteoarthritis
- Author
-
Nicoletta Zini, Alessandro Di Martino, Rosa Maria Borzì, Spartaco Santi, Brunella Grigolo, Carola Cavallo, Michele Guescini, Giuseppe Filardo, Giulia Merli, Stefania D'Adamo, Cavallo, Carola, Merli, Giulia, Borzì, Rosa Maria, Zini, Nicoletta, D'Adamo, Stefania, Guescini, Michele, Grigolo, Brunella, Di Martino, Alessandro, Santi, Spartaco, and Filardo, Giuseppe
- Subjects
0301 basic medicine ,Male ,Chemokine ,Molecular biology ,medicine.medical_treatment ,Adipose tissue ,Stem cells ,chemistry.chemical_compound ,0302 clinical medicine ,Gene expression ,Microscopy ,Multidisciplinary ,biology ,Chemistry ,Blotting ,NF-kappa B ,Middle Aged ,Synoviocytes ,Aged ,Blotting, Western ,Chondrocytes ,Extracellular Vesicles ,Female ,Humans ,Inflammation ,Microscopy, Electron, Transmission ,Osteoarthritis ,Real-Time Polymerase Chain Reaction ,Mesenchymal Stem Cell Transplantation ,Mesenchymal Stem Cells ,Cell biology ,Cytokine ,030220 oncology & carcinogenesis ,Medicine ,Western ,Stromal cell ,Science ,Electron ,Article ,03 medical and health sciences ,Rheumatology ,medicine ,Transmission ,Secretion ,NF-κB ,In vitro ,030104 developmental biology ,biology.protein ,Small Extracellular Vesicles, Adipose derived stromal cells, osteoarthritis, NF-κB, Inflammation - Abstract
The therapeutic ability of Mesenchymal Stem/Stromal Cells to address osteoarthritis (OA) is mainly related to the secretion of biologically active factors, which can be found within their secreted Extracellular Vesicles including small Extracellular Vesicles (sEV). Aim of this study was to investigate the effects of sEV from adipose derived stromal cells (ADSC) on both chondrocytes and synoviocytes, in order to gain insights into the mechanisms modulating the inflammatory/catabolic OA environment. sEV, obtained by a combined precipitation and size exclusion chromatography method, were quantified and characterized, and administered to chondrocytes and synoviocytes stimulated with IL-1β. Cellular uptake of sEV was evaluated from 1 to 12 h. Gene expression and protein release of cytokines/chemokines, catabolic and inflammatory molecules were analyzed at 4 and 15 h, when p65 nuclear translocation was investigated to study NF-κB pathway. This study underlined the potential of ADSC derived sEV to affect gene expression and protein release of both chondrocytes and synoviocytes, counteracting IL-1β induced inflammatory effects, and provided insights into their mechanisms of action. sEV uptake was faster in synoviocytes, where it also elicited stronger effects, especially in terms of cytokine and chemokine modulation. The inflammatory/catabolic environment mediated by NF-κB pathway was significantly attenuated by sEV, which hold promise as new therapeutic strategy to address OA.
- Published
- 2021